Experienced in Ectodermal Dysplasias

Ying L. Peng

103 Wenhua Rd, 
Shenyang, CN 
Experienced in Ectodermal Dysplasias
103 Wenhua Rd, 
Shenyang, CN 
OverviewLocationsClinical Research

Overview

Ying Peng practices in Shenyang, China. Ms. Peng is rated as an Experienced expert by MediFind in the treatment of Ectodermal Dysplasias. Her top areas of expertise are Mosaic Trisomy 9, Dilated Cardiomyopathy (DCM), Cirrhosis, Splenectomy, and Nephrectomy.

Her clinical research consists of co-authoring 665 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Ectodermal Dysplasias.

Gender
Female

Locations

103 Wenhua Rd, Shenyang, 110016, China
Other Locations
No. 87 Xiangya Road, Changsha, 410008, China
197 Ruijin 2nd Road, Shanghai, China
No. 1, Minde Road, Nanchang, 330006, China
37 Yiyuan Road, Harbin, 150006, China
No. 139, Renmin Middle Road, Changsha, 410011, China
20# South Renmin Road, Chengdu, 610041, China
37 Yiyuan Street, Harbin, 150086, China
NO.53 Xiangchun Road, Changsha, 410008, China
Yihuan Road, Chengdu, 610065, China
139 Renmin Middle Road, Changsha, 410011, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis: A Multicenter, Double-blind, Placebo-Controlled, Randomized Trial
Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis: A Multicenter, Double-blind, Placebo-Controlled, Randomized Trial
Enrollment Status: Suspended
Publish Date: December 04, 2017
Intervention Type: Other, Drug
Study Phase: Phase 2

665 Total Publications

Electro-oxidative [3+2] cycloaddition for the synthesis of 5-selenyltetrazoles.
Electro-oxidative [3+2] cycloaddition for the synthesis of 5-selenyltetrazoles.
Journal: Chemical communications (Cambridge, England)
Published: December 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Peng's expertise for a condition
ConditionClose
      View All 163 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile